Literature DB >> 24222369

Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.

Ajit Sood1, Vandana Midha, Omesh Goyal, Prerna Goyal, Neena Sood, Suresh Kumar Sharma.   

Abstract

PURPOSE/AIM: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality in all parts of the world. We analyzed the clinical presentation, etiology, and tumor characteristics of HCC presenting to our hospital.
METHODS: All patients diagnosed to have HCC from September 2007 to August 2010 were prospectively enrolled. HCC was diagnosed according to EASL criteria-USG/CT/MRI of the abdomen and/or serum alpha-fetoprotein and/or histology (where indicated). Detailed clinical and laboratory parameters were noted. Barcelona Clinic Liver Cancer (BCLC) staging was done.
RESULTS: One hundred and twenty-eight patients (22 females, mean ± SD; age, 49.8 ± 10.2 years) were diagnosed to have HCC. Underlying cirrhosis was present in 99.2 %. Hepatitis C virus infection, alone (21.9 %) or with alcohol (22.9 %) was the most common etiological factor, followed by alcohol alone; 33.6 % of the patients had more than one etiological factor. Most patients (83.5 %) presented with features of decompensated cirrhosis. HCC leading to decompensation of cirrhosis was the first presentation of the liver disease in nearly one third of the cases. Serum alpha-fetoprotein was >200 ng/mL in 67.2 % of the patients, while it was normal in 18.7 % of the patients. The mean ± SD size of HCC was 5.3 ± 2.9 cm. HCC was multicentric in 57 %, and portal vein thrombosis was present in 34.4 %. About 66 % of the patients belonged to BCLC stage C or D.
CONCLUSIONS: Hepatitis C virus infection was the most common cause of HCC in Punjab. One-third of the patients had multiple etiological factors and almost all had underlying cirrhosis and presented at advanced stage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24222369     DOI: 10.1007/s12664-013-0373-7

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  27 in total

1.  Primary hepatocellular carcinoma.

Authors:  J R Wands; H E Blum
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

2.  Comparative evaluation of serology and polymerase chain reaction for hepatitis C viral infection in liver diseases.

Authors:  P Kar; S Budhiraja; A Narang; B C Das; S K Panda; A Chakravorty
Journal:  Indian J Gastroenterol       Date:  1997-07

3.  Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: experience from an Indian center.

Authors:  Nitin Saini; Ashish Bhagat; Sanjeev Sharma; Ajay Duseja; Yogesh Chawla
Journal:  Clin Chim Acta       Date:  2006-05-02       Impact factor: 3.786

4.  Hepatocellular carcinoma: a clinicopathological study.

Authors:  Amanullah Abbasi; Nazish Butt; Abdul Rab Bhutto; Kashif Gulzar; S M Munir
Journal:  J Coll Physicians Surg Pak       Date:  2010-08       Impact factor: 0.711

5.  A study of ninety three cases of primary carcinoma of liver.

Authors:  S Patil; B K Bhuyan; B K Nanda
Journal:  Indian J Pathol Microbiol       Date:  1982-04       Impact factor: 0.740

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Authors:  S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das
Journal:  J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 4.029

8.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

9.  Hepatocellular carcinoma: analysis of 76 cases.

Authors:  A K Butt; A A Khan; A Alam; S Ahmad; S W Shah; F Shafqat; A B Naqvi
Journal:  J Pak Med Assoc       Date:  1998-07       Impact factor: 0.781

10.  Clinical and aetiological profile of hepatoma at a tertiary care centre.

Authors:  Nayana Joshi; Ajit Kumar; M Sudha Rani; Naval Chandra; E R Ramanjaneyulu
Journal:  Trop Gastroenterol       Date:  2003 Apr-Jun
View more
  3 in total

1.  Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.

Authors:  Suneel Tohra; Ajay Duseja; Sunil Taneja; Naveen Kalra; Ujjwal Gorsi; Arunanshu Behera; Lileswar Kaman; Divya Dahiya; Srimanta Sahu; Balkrishan Sharma; Virendra Singh; Radha K Dhiman; Yogesh Chawla
Journal:  J Clin Exp Hepatol       Date:  2021-02-11

2.  Clinical versus radiographical factors associated with hepatocellular carcinoma diagnosis in high-risk patients: sizes matter.

Authors:  Tanita Suttichaimongkol; Manoon Mitpracha; Kawin Tangvoraphonkchai; Phuangphaka Sadee; Kittisak Sawanyawisuth; Wattana Sukeepaisarnjaroen
Journal:  Future Sci OA       Date:  2022-02-02

3.  Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.

Authors:  Balaji Musunuri; Shiran Shetty; Ganesh Bhat; Karthik Udupa; Ananth Pai
Journal:  Indian J Gastroenterol       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.